Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 37.39B | 33.14B | 37.07B | 36.21B | 30.26B |
Gross Profit | 10.68B | 8.09B | 9.44B | 8.76B | 6.77B |
EBITDA | 5.18B | 1.60B | 3.16B | 2.35B | 454.00M |
Net Income | 3.43B | 767.00M | 1.76B | 981.00M | -28.00M |
Balance Sheet | |||||
Total Assets | 49.81B | 45.03B | 43.89B | 43.48B | 41.31B |
Cash, Cash Equivalents and Short-Term Investments | 22.29B | 16.66B | 20.68B | 19.48B | 18.48B |
Total Debt | 3.52B | 3.52B | 3.52B | 3.52B | 3.52B |
Total Liabilities | 15.84B | 14.83B | 15.20B | 16.46B | 14.28B |
Stockholders Equity | 33.97B | 30.20B | 28.70B | 27.02B | 27.03B |
Cash Flow | |||||
Free Cash Flow | 3.12B | -725.00M | 1.34B | 1.90B | -1.05B |
Operating Cash Flow | 3.33B | -322.00M | 1.59B | 2.60B | -689.00M |
Investing Cash Flow | 2.33B | -3.37B | -10.00M | -904.00M | -612.00M |
Financing Cash Flow | -434.00M | -324.00M | -390.00M | -594.00M | -591.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $12.47B | 3.63 | 1.31% | 12.83% | 347.44% | ||
78 Outperform | ¥10.15B | 12.01 | 2.60% | 19.85% | 78.11% | ||
73 Outperform | ¥9.56B | 5.39 | 3.74% | -2.30% | 16.63% | ||
73 Outperform | ¥16.09B | 25.07 | 1.64% | 26.93% | 35.46% | ||
70 Outperform | ¥7.07B | 11.49 | 3.02% | 0.78% | 106.93% | ||
64 Neutral | ¥11.80B | 18.82 | 1.86% | 8.01% | 28.74% | ||
63 Neutral | $16.62B | 10.98 | -6.98% | 2.96% | 1.73% | -24.23% |